Assura Plc (LON:AGR - Get Free Report)'s share price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 47.64 ($0.64) and traded as high as GBX 48.96 ($0.66). Assura shares last traded at GBX 48.37 ($0.65), with a volume of 12,421,799 shares changing hands.
Assura Stock Performance
The stock has a 50-day moving average price of GBX 49.52 and a 200 day moving average price of GBX 47.85. The firm has a market capitalization of £1.56 billion, a price-to-earnings ratio of 903.28, a P/E/G ratio of 3.60 and a beta of 0.37. The company has a quick ratio of 2.84, a current ratio of 0.89 and a debt-to-equity ratio of 85.05.
Assura (LON:AGR - Get Free Report) last issued its earnings results on Monday, July 21st. The real estate investment trust reported GBX 3.50 earnings per share for the quarter. Assura had a negative return on equity of 1.92% and a negative net margin of 18.09%. On average, analysts forecast that Assura Plc will post 3.5830389 EPS for the current year.
Insiders Place Their Bets
In other Assura news, insider Ed Smith sold 116,163 shares of the business's stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of GBX 49, for a total transaction of £56,919.87. Also, insider Jonathan Murphy sold 1,394,556 shares of the company's stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of GBX 50, for a total value of £697,278. In the last three months, insiders have bought 2,540 shares of company stock valued at $125,674 and have sold 5,182,149 shares valued at $258,872,495. 0.94% of the stock is currently owned by corporate insiders.
About Assura
(
Get Free Report)
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.
Further Reading
Before you consider Assura, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Assura wasn't on the list.
While Assura currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
